ZC3H8 is a zinc finger CCCH-type protein that functions as a transcriptional regulator with multiple roles in nuclear RNA metabolism and cell homeostasis. Mechanistically, ZC3H8 acts as a sequence-specific DNA-binding transcriptional repressor of the GATA3 promoter [UniProt] and serves as a core component of the little elongation complex (LEC), which collaborates with the 7SK snRNP to promote RNA polymerase II and III-dependent transcription of small nuclear RNAs (snRNAs) and small nucleolar RNAs (snoRNAs) 1. The protein localizes to Cajal bodies and PML bodies within the nucleus, with its localization regulated by casein kinase 2 phosphorylation 2. ZC3H8 is functionally important for T cell homeostasis, inducing thymocyte apoptosis when overexpressed, suggesting a regulatory role in thymic development [UniProt]. Loss of ZC3H8 expression in SCNM1-deficient cells impairs primary cilia function, linking ZC3H8 to ciliary homeostasis and Hedgehog signaling 3. Clinically, ZC3H8 is significantly overexpressed in breast cancer, where elevated expression associates with aggressive tumor phenotypes including increased proliferation, migration, invasion, and anchorage-independent growth 2. ZC3H8 also emerges as a prognostic marker in glioma and lung adenocarcinoma, being incorporated into immune-related prognostic signatures [PMID:34482648; 42]. These findings suggest ZC3H8 as a potential therapeutic target in cancer.